Potentially Highly Effective Drugs for COVID-19: Virtual Screening and Molecular Docking Study Through PyRx-Vina Approach

Potentially Highly Effective Drugs for COVID-19: Virtual Screening and Molecular Docking Study Through PyRx-Vina Approach

Introduction: The World Health Organization (WHO) has declared the novel coronavirus (COVID-2019) infection outbreak a global health emergency. Drug repurposing, which concerns the investigation of existing drugs for new therapeutic target indications, has emerged as a successful strategy for drug d...

Full description

Bibliographic Details
Main Authors:	Fatemeh Houshmand, Sara Houshmand
Format:	Article
Language:	English
Published:	Hamara Afzar 2023-08-01
Series:	Frontiers in Health Informatics
Subjects:	covid-19 protease inhibitor virtual screening docking corona virus sars-ncov2
Online Access:	http://ijmi.ir/index.php/IJMI/article/view/478

Similar Items

Comparing AutoDock and Vina in Ligand/Decoy Discrimination for Virtual Screening
by: Tatiana F. Vieira, et al.
Published: (2019-10-01)

Development and Validation of a Docking-Based Virtual Screening Platform for the Identification of New Lactate Dehydrogenase Inhibitors
by: Carlotta Granchi, et al.
Published: (2015-05-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Redesigning Vina@QNLM for Ultra-Large-Scale Molecular Docking and Screening on a Sunway Supercomputer
by: Hao Lu, et al.
Published: (2021-10-01)

Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease
by: Kenichi Akaji, et al.
Published: (2020-08-01)

Discovery of anti-SARS-CoV-2 agents from 38 Chinese patent drugs toward respiratory diseases via docking screening
by: Yong-Ming Yan, et al.
Published: (2023-02-01)

Discovery of anti-SARS-CoV-2 agents from commercially available flavor via docking screening
by: Jiaojiao Zhang, et al.
Published: (2023-02-01)

Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking
by: Reina Sasaki-Tanaka, et al.
Published: (2022-05-01)

Survey of public domain software for docking simulations and virtual screening
by: Biesiada Jacek, et al.
Published: (2011-07-01)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022-10-01)

Docking-based virtual screening of TβR1 inhibitors: evaluation of pose prediction and scoring functions
by: Shuai Wang, et al.
Published: (2020-08-01)

A Hybrid Docking and Machine Learning Approach to Enhance the Performance of Virtual Screening Carried out on Protein–Protein Interfaces
by: Natesh Singh, et al.
Published: (2022-11-01)

DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations
by: Alberto Cuzzolin, et al.
Published: (2015-05-01)

Virtual Screening in the Identification of Sirtuins’ Activity Modulators
by: Elena Abbotto, et al.
Published: (2022-09-01)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
by: Yi Zhang, et al.
Published: (2020-09-01)

Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening
by: Clara Blanes-Mira, et al.
Published: (2022-12-01)

Identification of Novel Potential Heparanase Inhibitors Using Virtual Screening
by: Alfredo Rus, et al.
Published: (2022-04-01)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
by: Hu Wang, et al.
Published: (2022-11-01)

Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors
by: Bingke Li, et al.
Published: (2019-06-01)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
by: Na Li, et al.
Published: (2022-12-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
by: Noor Atatreh, et al.
Published: (2019-01-01)

Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum
by: Yongze Yuan, et al.
Published: (2017-04-01)

Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
by: Yuwei Wang, et al.
Published: (2020-11-01)

Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
by: Ji-Xia Ren, et al.
Published: (2020-03-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
by: Menghan Gao, et al.
Published: (2023-07-01)

Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors
by: Naomi Scarano, et al.
Published: (2023-05-01)

Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting Hexokinase-II
by: Ruijuan Liu, et al.
Published: (2022-11-01)

A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening
by: Jacob Spiegel, et al.
Published: (2021-12-01)

Virtual Screening and Molecular Docking Studies for Discovery of Potential RNA-Dependent RNA Polymerase Inhibitors
by: Mohammed Y. Ghazwani, et al.
Published: (2021-04-01)

From Myricetin to the Discovery of Novel Natural Human ENPP1 Inhibitors: A Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and MM/GBSA Study
by: Shaohan Song, et al.
Published: (2022-09-01)

Virtual and In Vitro Screening of Natural Products Identifies Indole and Benzene Derivatives as Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>)
by: Dony Ang, et al.
Published: (2023-03-01)

Application of MM-PBSA Methods in Virtual Screening
by: Giulio Poli, et al.
Published: (2020-04-01)

Cross Docking Study Directed Toward Virtual Screening and Molecular Docking Study of Phenanthrene 1,2,4-triazine Derivatives As Novel Bcl-2 Inhibitors
by: Mohammad Hasan Jamei, et al.
Published: (2016-12-01)

An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings
by: Irene Maffucci, et al.
Published: (2018-03-01)

Insilico exploration of the potential inhibitory activity of DrugBank compounds against CDK7 kinase using structure-based virtual screening, molecular docking, and dynamics simulation approach
by: Afzal Hussain, et al.
Published: (2023-02-01)

Targeting the Human Influenza a Virus: The Methods, Limitations, and Pitfalls of Virtual Screening for Drug-like Candidates Including Scaffold Hopping and Compound Profiling
by: Thomas Scior, et al.
Published: (2023-04-01)

Identification of potential antiviral lead inhibitors against SARS-CoV-2 main protease: Structure-guided virtual screening, docking, ADME, and MD Simulation based approach
by: Goverdhan Lanka, et al.
Published: (2023-12-01)

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
by: Marcin Cieślak, et al.
Published: (2024-04-01)

Accelerating AutoDock Vina with GPUs
by: Shidi Tang, et al.
Published: (2022-05-01)